{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "S. 2236"}, "official-title": {"#tail": "\n  ", "#text": "To amend the Public Health Service Act to enhance efforts to address antimicrobial resistance, and\n\t\t\t for other purposes."}, "session": {"#tail": "\n    ", "#text": "2d Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20140410", "#text": "April 10, 2014"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "sponsor": {"#tail": " introduced the following bill; which was read twice and referred to the ", "#text": "Mr. Brown", "@name-id": "S307"}, "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Strategies to Address Antimicrobial\n\t\t\t Resistance Act", "@value": "Strategies to Address Antimicrobial Resistance Act", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H517BC4B2EDBA4F1588936DD35C12E4C3"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " finds as follows:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "The advent of the\n\t\t\t antibiotic era has saved millions of lives and allowed for incredible\n\t\t\t medical\n\t\t\t progress; however, the increased use and overuse of antimicrobial drugs\n\t\t\t have\n\t\t\t correlated with increased rates of antimicrobial resistance."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "HB78566AF791C46A7B02D02772F004D73", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Through mutation\n\t\t\t as well as other mechanisms, bacteria and other infectious disease-causing\n\t\t\t organisms\u2014viruses, fungi, and parasites\u2014develop resistance to\n\t\t\t antimicrobial\n\t\t\t drugs over time. The more antimicrobial drugs are used, whether\n\t\t\t appropriately\n\t\t\t or inappropriately, the more this contributes to the development of\n\t\t\t antimicrobial resistance."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H78AC89EBFAC0492D801DA744C8DFBEE9", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Scientific\n\t\t\t evidence suggests that the development of antimicrobial resistance in\n\t\t\t humans is\n\t\t\t not due only to use of antimicrobial drugs in humans, but also may be\n\t\t\t caused by\n\t\t\t the use of antimicrobial drugs in food-producing animals."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "HF01C4595AD7A4852B90DCAA94EC93345", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "A\n\t\t\t study estimates that in 2005 more than 94,000 invasive\n\t\t\t methicillin-resistant\n\t\t\t Staphylococcus aureus (MRSA) bacterial infections occurred in the United\n\t\t\t States\n\t\t\t and more than 18,500 of these infections resulted in death\u20147 times more\n\t\t\t than a\n\t\t\t decade earlier."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H2C1EEB3DAEA94171BCE7AC977A7D5F10", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "The 2009 Influenza\n\t\t\t A: H1N1 virus outbreak, and the yearly seasonal influenza outbreaks,\n\t\t\t exacerbate\n\t\t\t concerns about antiviral resistance given that so few antivirals are\n\t\t\t available\n\t\t\t to treat influenza as well as secondary bacterial infections due to MRSA,\n\t\t\t antibiotic-resistant Streptococcus pneumonia, and other bacteria that\n\t\t\t cause\n\t\t\t respiratory diseases. Given that, during the 1918 influenza pandemic, many\n\t\t\t thousands of deaths were caused by complications due to secondary\n\t\t\t bacterial\n\t\t\t infections and not by the influenza virus itself."}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "H34D7D62E98A545F69DC71393AA853432", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "Each year, nearly\n\t\t\t 2,000,000 people contract bacterial infections in hospitals and\n\t\t\t approximately\n\t\t\t 90,000 of these people die from these infections. Many of these infections\n\t\t\t are\n\t\t\t resistant to one or more commonly used antibiotics."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "HA98D3263F54447449DDD476B2F15CB20", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "term": {"#tail": ", September 2012) found that each antibiotic-resistant infection\n\t\t\t costs, on average, over $15,000 more to treat than susceptible\n\t\t\t infections.", "#text": "Clinical Infectious\n\t\t\t Disease"}, "#text": "A\n\t\t\t 2012 study conducted at Columbia University ("}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "H63A85114B96540B6BB2D3969ADFE41C2", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "The costs of\n\t\t\t antimicrobial-resistant infections in terms of lives lost and the economy\n\t\t\t will\n\t\t\t only rise as antimicrobial resistance continues to spread."}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "@id": "H56A75B2442414E87A522E51697C5175B", "#text": "\n        "}], "#text": "\n      ", "@id": "HF16DD609B9D94799AD333696713019DF"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 319E of the Public Health Service Act", "@value": "Public Health Service Act/s:319E"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "\n          42 U.S.C. 247d\u20135", "@value": "usc/42/247d\u20135"}, "@parsable-cite": "usc/42/247d-5", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Antimicrobial\n\t\t\t resistance task force"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subsection\n\t\t\t (a)", "@value": "Public Health Service Act/s:319E/ss:a"}, "#text": "in "}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "#text": "\n        ", "@id": "HBFBA07BFDBDD472AA2496AB69D516268", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting the following:\n\t\t\t ", "header-in-text": {"#tail": "\n            ", "@style": "OLC", "#text": "Task\n\t\t\t Force", "@level": "subsection"}, "#text": "\n              "}, {"#tail": ";", "header-in-text": {"#tail": "\n            ", "@style": "OLC", "#text": "Antimicrobial Resistance\n\t\t\t Office, Task Force, and Advisory Board", "@level": "subsection"}, "#text": "\n              "}], "#text": "in the subsection\n\t\t\t heading, by striking "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H68DA0F305A7B43B6AE032442234A3D5E", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph\n\t\t\t (1)", "@value": "Public Health Service Act/s:319E/ss:a/p:1"}, "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "clause": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "quote": [{"#tail": " and\n\t\t\t inserting ", "#text": "as of the date of the enactment of this section"}, {"#tail": "; and", "#text": "as of September 30, 2006"}], "#text": "by\n\t\t\t striking "}, "enum": {"#tail": "\n            ", "#text": "(i)"}, "@id": "H292353FDB6534B6498403DAA6145A2AE", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "quote": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall, not later than 1\n\t\t\t year after the date of enactment of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", direct the ", "@entity-type": "act", "#text": "Strategies to Address\n\t\t\t Antimicrobial\n\t\t\t Resistance Act", "@value": "Strategies to Address Antimicrobial Resistance Act", "@proposed": "true"}, {"#tail": " to establish an\n\t\t\t ", "@entity-type": "federal-body", "#text": "Assistant Secretary of Health", "@entity-id": "7521"}, {"@proposed": "true", "#tail": " and appoint a director to that ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Antimicrobial Resistance Office"}, {"@proposed": "true", "#tail": ". The\n\t\t\t ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Office"}, {"#tail": " shall, not later than 1 year after the date of enactment of such\n\t\t\t Act,\n\t\t\t establish the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"@proposed": "true", "#tail": " as an advisory\n\t\t\t board\n\t\t\t to the ", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health Antimicrobial Advisory Board"}, {"@proposed": "true", "#tail": ". The ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the Antimicrobial Resistance Office"}, {"@proposed": "true", "#tail": " shall serve as the ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of\n\t\t\t the\n\t\t\t Antimicrobial Resistance Office"}, {"@proposed": "true", "#tail": ". To avoid duplication and ensure that\n\t\t\t Federal resources are used efficiently and effectively, the Director shall\n\t\t\t work\n\t\t\t in conjunction with the Federal agencies represented on the ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Director of the\n\t\t\t Antimicrobial Resistance Task Force"}, {"@proposed": "true", "#tail": " to\n\t\t\t coordinate all antimicrobial resistance activities undertaken and\n\t\t\t supported by\n\t\t\t the Federal Government, including the activities and budgetary allocations\n\t\t\t of\n\t\t\t the ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Task Force"}, {"@proposed": "true", "#tail": ", ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Office"}, {"@proposed": "true", "#tail": ", and ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Task Force"}, {"@proposed": "true", "#tail": ".", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health Antimicrobial Advisory\n\t\t\t Board"}], "#text": "The "}, "#text": "by\n\t\t\t adding at the end the following: "}, "enum": {"#tail": "\n            ", "#text": "(ii)"}, "@id": "H72406EFF398343DFB5EC083908DF9D38", "#text": "\n            "}], "#text": "\n          ", "@id": "HFD3C55BEF8E34795B66D690D7ECAD9D6"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to read as follows:", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Public Health Service Act/s:319E/ss:a/p:2", "@proposed": "true"}, "#text": "by amending\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": ";"}, "#tail": "\n        ", "paragraph": {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ".", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Antimicrobial\n\t\t\t\tResistance Office"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H4EA00CB378354A0496523A867FA9FACB", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-parent-id": "7500", "@entity-type": "federal-body", "#text": "Assistant\n\t\t\t\tSecretary for Preparedness and Response", "@value": "Office of the Assistant Secretary for Preparedness and Response"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H17DFDD2491D14141B76D0FFFC885F180", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-parent-id": "7500", "@entity-type": "federal-body", "#text": "Biomedical\n\t\t\t\tAdvanced Research and Development Authority", "@value": "Biomedical Advanced Research and Development Authority"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "H89B26B139338495484A1EF3B572EF59F", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Centers for\n\t\t\t\tDisease Control and Prevention", "@entity-id": "7523"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "H1914E54425BB4D68B60912AFCCF64004", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "@id": "HC560AAF9B1624E439EEFC25C28CC2E15", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "National\n\t\t\t\tInstitutes of Health", "@entity-id": "7529"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(vi)"}, "@id": "H977E2353522A4EA292C59BA7D9C0F58C", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Agency for\n\t\t\t\tHealthcare Research and Quality", "@entity-id": "7528"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(vii)"}, "@id": "H8CCCF822FF634E7A9629914D6476C223", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Centers for\n\t\t\t\tMedicare & Medicaid Services", "@entity-id": "7530"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(viii)"}, "@id": "HC04016406E3E45A188D1FE870F290299", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Health\n\t\t\t\tResources and Services Administration", "@entity-id": "7526"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(ix)"}, "@id": "HE5FE332A0415420D9233A44B11A5EE16", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Department of\n\t\t\t\tAgriculture", "@entity-id": "1200"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(x)"}, "@id": "H13BCC322FECF436B8BF79EB6D2EAA713", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Department of\n\t\t\t\tEducation", "@entity-id": "9100"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(xi)"}, "@id": "HC92EFC7797654C55BD98A5AC81AB1193", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Department\n\t\t\t\tof Defense", "@entity-id": "9700"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(xii)"}, "@id": "HE8AE912E5A064E52BF3816DCE2030DD8", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Department\n\t\t\t\tof Veterans Affairs", "@entity-id": "3600"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(xiii)"}, "@id": "HA750257366BB4B358AD5137FD7C415A8", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Environmental Protection Agency", "@entity-id": "6800"}, "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(xiv)"}, "@id": "H5DABD0B8E9494F208D6A42D15ADA4F52", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Department of\n\t\t\t\tHomeland Security", "@entity-id": "7000"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(xv)"}, "@id": "HCD457B59FFC046C59928F835DFDF702B", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "United\n\t\t\t\tStates Agency for International Development", "@entity-id": "7200"}, "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(xvi)"}, "@id": "HC193AAB425444864B5DFD53740468984", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "Members of the\n\t\t\t\tantimicrobial resistance task force"}, "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be composed of representatives of such Federal\n\t\t\t agencies as\n\t\t\t\tthe ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:319E/ss:a/p:1"}, {"#tail": " determines necessary, including representation of the\n\t\t\t\tfollowing:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The task force described in\n\t\t\t\t"}, "#text": "\n                ", "@id": "H33AFEAEE0D74485C961F3ECF8E368133"}, {"#tail": "\n            ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall be\n\t\t\t\tcomposed of 19 voting members, appointed by the ", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health Antimicrobial Advisory Board"}, {"#tail": ". Such\n\t\t\t members shall\n\t\t\t\tinclude experts from the medical professions (including hospital\n\t\t\t and\n\t\t\t\tcommunity-based physicians), pharmacy, public health, veterinary,\n\t\t\t research, and\n\t\t\t\tinternational health communities, as well as one representative\n\t\t\t from a public\n\t\t\t\tinterest group.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "H8F65C7AFFAD6444ABC28E80768DCA38F"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "6 shall be\n\t\t\t\tappointed for a term of 12 months; and"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "HC69A4A3AD71748B2987C41ABA1F9C11B", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n                  ", "#text": "6 shall be\n\t\t\t\tappointed for a term of 2 years."}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "HBD31204C21684856AE69ACFE5573A44E", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "header": {"#tail": "\n                  ", "#text": "Terms"}, "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be appointed for a term of\n\t\t\t 3 years,\n\t\t\t\texcept that of the 19 members first appointed\u2014", "@entity-type": "act", "#text": "clause (i)", "@value": "Public Health Service Act/s:319E/ss:a/p:2/sp:B/cl:i", "@proposed": "true"}, "#text": "Each\n\t\t\t\tmember appointed under "}, "#text": "\n                  ", "@id": "H2FFD721770A94DEB81F4721EC341FF17"}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall appoint a ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"@proposed": "true", "#tail": " from among its members to lead and supervise the activities\n\t\t\t of the\n\t\t\t\t", "@entity-type": "federal-body", "@value": "Chair of the Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Chair of the Public Health Antimicrobial\n\t\t\t Advisory\n\t\t\t\tBoard"}, {"@proposed": "true", "#tail": ".", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Advisory Board"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "header": {"#tail": "\n                  ", "#text": "Chair"}, "#text": "\n                  ", "@id": "H74BC098BCB584A4A9E3EA98939BFD109"}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": ", each member of the ", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health\n\t\t\t\tAntimicrobial Advisory Board"}, {"@proposed": "true", "#tail": "\n\t\t\t shall disclose\n\t\t\t\tto the ", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Advisory Board"}, {"#tail": " any potential, relevant financial interests as\n\t\t\t defined under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "uscode", "#text": "\n                      ", "external-xref": {"#tail": " of title 18, United States\n\t\t\t\tCode", "@parsable-cite": "usc/18/208", "#text": "section 208(a)", "@legal-doc": "usc"}, "@value": "usc/18/208/a"}], "#text": "Prior to a meeting of the "}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "header": {"#tail": "\n                  ", "#text": "Disclosure of\n\t\t\t\tfinancial interests"}, "#text": "\n                  ", "@id": "HBF61609EAE5B4AC5A1F272F5F58D5E92"}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Members of the\n\t\t\t\tpublic health antimicrobial advisory board"}, "#text": "\n                ", "@id": "H173F1052025D4E13BFAE2C0D0C436864"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Members"}, "#text": "\n              ", "@id": "H6AC59EF3ABD0442EB9B002174A4D288E"}, "#text": "\n            ", "@id": "HB7A6D0EF49B24235AD44FEC46F1F88E0"}, "#text": "\n          ", "@id": "H21936F2C917C48B7992B76479FD2303C"}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "paragraph\n\t\t\t (3)(B)", "@value": "Public Health Service Act/s:319E/ss:a/p:3/sp:B", "@proposed": "true"}, "#text": "in ", "quote": [{"#tail": " and inserting ", "#text": "in consultation with the task force described in\n\t\t\t paragraph (1) and"}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " and the ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of\n\t\t\t the Antimicrobial Resistance Office"}, {"#tail": ", and in consultation with", "@entity-type": "federal-body", "#text": "Director of the Centers for\n\t\t\t Disease\n\t\t\t Control and Prevention", "@entity-id": "7523"}], "#text": "acting through the "}]}, "enum": {"#tail": "\n          ", "#text": "(D)"}, "@id": "H99B2FE043EB7478689061DCCC7EB06FB", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to read as follows:", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Public Health Service Act/s:319E/ss:a/p:4", "@proposed": "true"}, "#text": "by amending\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(E)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": ";"}, "#tail": "\n        ", "paragraph": {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "establish\n\t\t\t\tbenchmarks for achieving the goals set forth in the action plan;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HFE09D4A68B6740C0A5C0BC9B37C7BDA3", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "assess the\n\t\t\t\tongoing, observed patterns of emergence of antimicrobial\n\t\t\t resistance, and their\n\t\t\t\timpact on clinical outcomes in terms of how patients feel,\n\t\t\t function, or\n\t\t\t\tsurvive;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H76577B4A7577415A8A239BB580999C60", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "assess how\n\t\t\t\tantimicrobial products are being used in humans, animals, plants,\n\t\t\t and the\n\t\t\t\tenvironment and the risks and benefits of those uses in furthering\n\t\t\t the\n\t\t\t\tdevelopment of resistance and the implications thereof for patient\n\t\t\t safety and\n\t\t\t\tpublic health;"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "H8700417C3A314585A0D875A807D77ADE", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "establish a\n\t\t\t\tpriority list of human infectious diseases with the greatest need\n\t\t\t for\n\t\t\t\tdevelopment of new point-of-care and other diagnostics,\n\t\t\t antimicrobial drugs,\n\t\t\t\tand vaccines, and in particular serious and life-threatening\n\t\t\t resistant\n\t\t\t\tinfections, for which there are few or no diagnostic, treatment, or\n\t\t\t prevention\n\t\t\t\toptions;"}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "H35A8C53AFCA7462A9AD233E745E862F0", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "recommend basic,\n\t\t\t\tclinical, epidemiological, prevention, and translational research\n\t\t\t where\n\t\t\t\tadditional federally supported studies may be beneficial;"}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "@id": "H603B5212B5AD4AC8ACCE7BD20FCC2ABC", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tactivities, including through the agency\u2019s Critical Path Initiative\n\t\t\t and the\n\t\t\t\tReagan-Udall Foundation;", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t Administration", "@entity-id": "7524"}, "#text": "recommend how to\n\t\t\t\tsupport antimicrobial development through "}, "enum": {"#tail": "\n                  ", "#text": "(vi)"}, "@id": "H2B58BB759515467D80EC8CEC396C6DB1", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "recommend how\n\t\t\t\tbest to strengthen and link antimicrobial resistance-related\n\t\t\t surveillance and\n\t\t\t\tprevention and control activities; and"}, "enum": {"#tail": "\n                  ", "#text": "(vii)"}, "@id": "H8DCE4490DD054F0590EF643028E05A9D", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to\n\t\t\t ensure that\n\t\t\t\tstrategies to address antimicrobial-resistance are coordinated with\n\t\t\t initiatives\n\t\t\t\taimed at pandemic influenza, severe acute respiratory syndrome, and\n\t\t\t\tbioterrorism.", "@entity-parent-id": "7500", "@entity-type": "federal-body", "#text": "Assistant Secretary for Preparedness and Response", "@value": "Office of the Assistant Secretary for Preparedness and Response"}, "#text": "collaborate\n\t\t\t\twith the "}, "enum": {"#tail": "\n                  ", "#text": "(viii)"}, "@id": "H503EBCD00CE349128B94ABAFFB3C90DA", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "Antimicrobial\n\t\t\t\tresistance office duties"}, "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": ", working in conjunction with the Federal agencies\n\t\t\t that are\n\t\t\t\trepresented on the task force described in ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the Antimicrobial\n\t\t\t\tResistance Office"}, {"#tail": ", shall\n\t\t\t issue an update\n\t\t\t\tto the Public Health Action Plan to Combat Antimicrobial Resistance\n\t\t\t within 1\n\t\t\t\tyear of the establishment of the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:319E/ss:a/p:1"}, {"@proposed": "true", "#tail": " and annually thereafter.\n\t\t\t The updates\n\t\t\t\tshall include enhanced plans for addressing antimicrobial\n\t\t\t resistance in the\n\t\t\t\tUnited States and internationally. The ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Office"}, {"@proposed": "true", "#tail": " shall\n\t\t\t post on a\n\t\t\t\twebsite these updates as well as summaries of all non-proprietary\n\t\t\t data the ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the Office"}, {"@proposed": "true", "#tail": " makes available. The ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Task\n\t\t\t\tForce"}, {"@proposed": "true", "#tail": "\n\t\t\t\tshall work in conjunction with the Federal agencies that are\n\t\t\t represented on the\n\t\t\t\ttask force described in ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the Antimicrobial Resistance\n\t\t\t Office"}, {"#tail": ", and in consultation with the\n\t\t\t ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:319E/ss:a/p:1"}, {"@proposed": "true", "#tail": ", to\u2014", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public\n\t\t\t\tHealth Antimicrobial Advisory Board"}], "#text": "The "}, "#text": "\n                ", "@id": "HD5BB2013B9B0437DA4CF0ACC28C01A37"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall convene periodically as\n\t\t\t the ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Antimicrobial Resistance Task Force"}, {"@proposed": "true", "#tail": " determines to be\n\t\t\t appropriate, but\n\t\t\t\tnot fewer than twice a year, to consider issues relating to\n\t\t\t antimicrobial\n\t\t\t\tresistance.", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Director\n\t\t\t\tof the Antimicrobial Resistance Task Force"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "header": {"#tail": "\n                  ", "#text": "Meetings"}, "#text": "\n                  ", "@id": "H0A9875B94A9745B7B4F6C79E96DE9139"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "antimicrobial\n\t\t\t\tclinical susceptibility concentrations proposed, established, or\n\t\t\t updated by the\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "H96A6EEBA35D4411BB95D888E71B3C74F", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "data obtained by\n\t\t\t\tgovernment agencies and, as possible, by private sources on\n\t\t\t emerging\n\t\t\t\tantimicrobial resistance related to clinical outcomes as well as\n\t\t\t data related\n\t\t\t\tto how antimicrobial drugs may have been used inappropriately;"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H04C619EEAC1C47A79EAB86FD9BBEB06C", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "federal-body", "#text": "Centers for Disease\n\t\t\t Control and\n\t\t\t\tPrevention", "@entity-id": "7523"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ", the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Department of\n\t\t\t Defense", "@entity-id": "9700"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Department of Veterans Affairs", "@entity-id": "3600"}, {"#tail": ", the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Department of Agriculture", "@entity-id": "1200"}, {"#tail": ", and as feasible from private\n\t\t\t sources and\n\t\t\t\tinternational bodies;", "@entity-type": "federal-body", "#text": "Environmental Protection Agency", "@entity-id": "6800"}], "#text": "surveillance\n\t\t\t\tdata and prevention and control activities regarding emerging\n\t\t\t antimicrobial\n\t\t\t\tresistance from reliable sources including the "}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "H6D63D36BD5934DC5BFA2B402006AFCD9", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "federal-body", "#text": "Centers\n\t\t\t for Disease\n\t\t\t\tControl and Prevention", "@entity-id": "7523"}, {"#tail": ", the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Environmental\n\t\t\t\tProtection Agency", "@entity-id": "6800"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Department of Veterans Affairs", "@entity-id": "3600"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Centers\n\t\t\t for Medicare\n\t\t\t\t& Medicaid Services", "@entity-id": "7530"}, {"#tail": ", and the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Department of Homeland Security", "@entity-id": "7000"}, {"#tail": ", and as feasible from private sources and\n\t\t\t\tinternational bodies;", "@entity-type": "federal-body", "#text": "Department of Agriculture", "@entity-id": "1200"}], "#text": "data on the\n\t\t\t\tamount of antimicrobial products used in humans, animals, plants,\n\t\t\t and the\n\t\t\t\tenvironment from reliable sources, including data from the "}, "enum": {"#tail": "\n                    ", "#text": "(IV)"}, "@id": "HE6250CC0E6BD441395965245D069E688", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "the impact of\n\t\t\t\tantimicrobial resistance on human health resulting from the\n\t\t\t approval of\n\t\t\t\tantimicrobial drugs for use in humans, animals, or plants\n\t\t\t (including\n\t\t\t\tconsideration of and recommendations on potential management plans\n\t\t\t to limit and\n\t\t\t\treduce the negative impacts of such resistance on human health and\n\t\t\t\tconsideration of the benefits to animal health and food safety);"}, "enum": {"#tail": "\n                    ", "#text": "(V)"}, "@id": "H4E5375E28CA14A79A609791D1D57F921", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "reports of federally supported\n\t\t\t\tantimicrobial resistance research and antimicrobial drug, related\n\t\t\t diagnostics,\n\t\t\t\tand vaccine development for antimicrobial resistant infections\n\t\t\t (such as\n\t\t\t\tmethicillin-resistant Staphylococcus aureus (MRSA)) and other\n\t\t\t research\n\t\t\t\tactivities (including clinical, epidemiological, prevention, and\n\t\t\t\ttrans\u00adla\u00adtion\u00adal research) obtained from Federal agencies, as well\n\t\t\t as reports\n\t\t\t\tof research sponsored by other countries, industry, and\n\t\t\t non-governmental\n\t\t\t\torganizations;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(VI)"}, "@id": "H8FD06A3AC4A042A29A5CB362F9093321", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to develop policies and\n\t\t\t guidance\n\t\t\t\twhich encourage antimicrobial drug, related diagnostics, and\n\t\t\t vaccine\n\t\t\t\tdevelopment and appropriate use while maintaining high standards\n\t\t\t for safety and\n\t\t\t\teffectiveness;", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "reports on\n\t\t\t\tefforts by the "}, "enum": {"#tail": "\n                    ", "#text": "(VII)"}, "@id": "H56601F3E183640908926658E2DB31C7D", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "quality\n\t\t\t\tmeasures, which may include health plan employer data and\n\t\t\t information set\n\t\t\t\t(HEDIS) measures, pertaining to appropriate use of antimicrobial\n\t\t\t drugs;\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(VIII)"}, "@id": "H053BE230190A4D88A90952DF588E56AC", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " identifies as\n\t\t\t relevant to the\n\t\t\t\tissue of antimicrobial resistance.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:319E/ss:a/p:1", "@proposed": "true"}, "#text": "other data and\n\t\t\t\tissues the task force described in "}, "enum": {"#tail": "\n                    ", "#text": "(IX)"}, "@id": "H62C8A5D7349A4BB8B038956B4701794F", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "header": {"#tail": "\n                  ", "#text": "Public health\n\t\t\t\taction plan"}, "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall have a meeting to review, discuss, and further\n\t\t\t develop the\n\t\t\t\tPublic Health Action Plan to Combat Antimicrobial Resistance first\n\t\t\t issued by\n\t\t\t\tthe interagency task force on antimicrobial resistance in 2001.\n\t\t\t Among other\n\t\t\t\tissues, the task force may discuss and review, based on current\n\t\t\t need or\n\t\t\t\tconcern\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:319E/ss:a/p:1"}, "#text": "At least twice a year, the task force described in\n\t\t\t\t"}, "#text": "\n                  ", "@id": "H05EB27D66A2C435D994D2FD7BF2A852E"}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may consult with\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"@proposed": "true", "#tail": " concerning the\n\t\t\t pending\n\t\t\t\tapplication of any antimicrobial drug application submitted to the\n\t\t\t ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the Antimicrobial Resistance Office"}, {"#tail": "\n\t\t\t\tunder ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or ", "@entity-type": "act", "#text": "section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505"}, {"#tail": " or the\n\t\t\t\t", "@entity-type": "act", "#text": "512 of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ".", "@entity-type": "act", "#text": "Public Health Service Act", "@value": "Public Health Service Act"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "header": {"#tail": "\n                  ", "#text": "Pending\n\t\t\t\tapplications"}, "#text": "\n                  ", "@id": "HB1FFC6D8FBC646999C6E6A7745AD661B"}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Antimicrobial\n\t\t\t\tresistance task force meetings and duties"}, "#text": "\n                ", "@id": "HF61C766DF3A94D09AE23BC5CE40585C4"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall meet as the ", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health Antimicrobial Advisory Board"}, {"@proposed": "true", "#tail": " determines to be\n\t\t\t appropriate,\n\t\t\t\tpreferably in conjunction with meetings of the ", "@entity-type": "federal-body", "@value": "Chair of the Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Chair\n\t\t\t of the\n\t\t\t\tPublic Health Antimicrobial Advisory Board"}, {"@proposed": "true", "#tail": ", but not fewer than 2 times each year.", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Antimicrobial\n\t\t\t Resistance Task\n\t\t\t\tForce"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "header": {"#tail": "\n                  ", "#text": "Meetings"}, "#text": "\n                  ", "@id": "H237325FB7B764019BEF8DE884615597E"}, {"#tail": "\n              ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "ways to encourage\n\t\t\t\tthe availability of an adequate supply of safe and effective\n\t\t\t antimicrobial\n\t\t\t\tproducts, related diagnostics, and vaccines;"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "H247298D56FCF48CB91016F3E1ABCFF06", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "research\n\t\t\t\tpriorities and other measures (such as antimicrobial drug\n\t\t\t resistance management\n\t\t\t\tplans) to enhance the safety and efficacy of antimicrobial\n\t\t\t products;"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H71040AD137544842ADC725752898D7FF", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "how best to\n\t\t\t\timplement and update the goals of the Public Health Action Plan to\n\t\t\t Combat\n\t\t\t\tAntimicrobial Resistance;"}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "HAA0985B30E73446A9F011839B97E9CD9", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "incentives\n\t\t\t\tnecessary to establish uniform mechanisms (which could include\n\t\t\t electronic\n\t\t\t\tsurveillance systems) and data sets for State and local reporting\n\t\t\t of\n\t\t\t\tresistance;"}, "enum": {"#tail": "\n                    ", "#text": "(IV)"}, "@id": "H1110605785774561B94D765BAC19A2F2", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "the adequacy of\n\t\t\t\texisting United States antimicrobial resistance and use\n\t\t\t surveillance;"}, "enum": {"#tail": "\n                    ", "#text": "(V)"}, "@id": "HC5B62BF2C89A4EF3933CD1C9E75F02D5", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "the development\n\t\t\t\tof a national plan for the collection and analysis of isolates of\n\t\t\t resistant\n\t\t\t\tpathogens, including establishing priorities as to which isolates\n\t\t\t should be\n\t\t\t\tcollected; and"}, "enum": {"#tail": "\n                    ", "#text": "(VI)"}, "@id": "H9EE13FB9F89F48F59E31666A9DE05568", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n                  ", "#text": "areas for\n\t\t\t\tgovernment, nongovernment, and international cooperation to\n\t\t\t strengthen\n\t\t\t\timplementation of the Public Health Action Plan to Combat\n\t\t\t Antimicrobial\n\t\t\t\tResistance."}, "enum": {"#tail": "\n                    ", "#text": "(VII)"}, "@id": "H6E1A40F82DFA4030B622C4A85001A356", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "header": {"#tail": "\n                  ", "#text": "Recommendations"}, "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall make\n\t\t\t recommendations to the\n\t\t\t\t", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health Antimicrobial Advisory Board"}, {"#tail": ", and the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"@proposed": "true", "#tail": ", regarding\u2014", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Antimicrobial Resistance Office"}], "#text": "The\n\t\t\t\t"}, "#text": "\n                  ", "@id": "H245F4215F6C44425A2FA760BB6146B59"}], "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Public health\n\t\t\t\tantimicrobial advisory board meetings and duties"}, "#text": "\n                ", "@id": "H21CA9BFB86ED481887B78F9AAEAD1780"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall ensure that\n\t\t\t\tall information shall be made available to the public on the\n\t\t\t website described\n\t\t\t\tin ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Antimicrobial Resistance Office"}, {"#tail": " consistent with ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Public Health Service Act/s:319E/ss:a/p:4/sp:A", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section 9 of the Strategies to\n\t\t\t Address\n\t\t\t\tAntimicrobial Resistance\n\t\t\t\tAct", "@value": "Strategies to Address Antimicrobial Resistance Act/s:9", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "header": {"#tail": "\n                ", "#text": "Availability of\n\t\t\t\tinformation"}, "#text": "\n                ", "@id": "HC882CFE40BEE4154A99ADC92F2A81E9D"}], "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Meetings and\n\t\t\t\tduties"}, "#text": "\n              ", "@id": "HC859C07D5E8F42F1B0083F7527C847E3"}, "#text": "\n            ", "@id": "HC1D16AA105DC49F9ACFF1CAE1562D157"}, "#text": "\n          ", "@id": "HED448A5DD756461BA1690AF2BDCEF438"}]}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to read as follows:", "@entity-type": "act", "#text": "subsection (b)", "@value": "Public Health Service Act/s:319E/ss:b"}, "#text": "by amending\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": ";"}, "#tail": "\n      ", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", working in\n\t\t\t consultation with\n\t\t\t\tthe ", "@entity-type": "federal-body", "#text": "Director of the National Institutes of Health", "@entity-id": "7529"}, {"#tail": ", the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease Control and Prevention", "@entity-id": "7523"}, {"#tail": ", the ", "@entity-parent-id": "7500", "@entity-type": "federal-body", "#text": "Assistant\n\t\t\t\tSecretary for Preparedness and Response", "@value": "Office of the Assistant Secretary for Preparedness and Response"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Director of the\n\t\t\t Biomedical\n\t\t\t\tAdvanced Research and Development Authority", "@entity-id": "7500"}, {"@proposed": "true", "#tail": ", the ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the\n\t\t\t Antimicrobial\n\t\t\t\tResistance Office"}, {"@proposed": "true", "#tail": ",\n\t\t\t and other\n\t\t\t\tnon-government experts, including representatives from professional\n\t\t\t societies\n\t\t\t\tand the pharmaceutical, vaccine, and medical device industries, and\n\t\t\t other\n\t\t\t\tFederal agencies shall develop a blue-ribbon antimicrobial\n\t\t\t resistance strategic\n\t\t\t\tresearch plan that strengthens existing epidemiological,\n\t\t\t interventional,\n\t\t\t\tclinical, behavioral, translational, and basic research efforts to\n\t\t\t advance the\n\t\t\t\tunderstanding of\u2014", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health Antimicrobial Advisory Board"}], "#text": "The "}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Antimicrobial\n\t\t\t\tresistance strategic research plan"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "the development,\n\t\t\t\timplementation, and efficacy of interventions to prevent and\n\t\t\t control the\n\t\t\t\temergence and transmission of antimicrobial resistance;"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H27E3A70CC3654E6888977FCD9F7D0193", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "how best to\n\t\t\t\toptimize antimicrobial effectiveness while limiting the emergence\n\t\t\t of\n\t\t\t\tresistance, including addressing issues related to duration of\n\t\t\t therapy,\n\t\t\t\teffectiveness of therapy in self-resolving diseases, and\n\t\t\t determining\n\t\t\t\tpopulations most likely to benefit from antimicrobial drugs;"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "HDEDD84D2A16845008419E91F42FCD22E", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "the extent to\n\t\t\t\twhich specific uses of antimicrobial products in humans, animals,\n\t\t\t plants, and\n\t\t\t\tother uses accelerate development and transmission of antimicrobial\n\t\t\t\tresistance;"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "H4C6A7348372748838203AFD1CAE88568", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "the natural\n\t\t\t\thistories of infectious diseases (including defining the disease,\n\t\t\t diagnosis,\n\t\t\t\tseverity, and the time course of illness);"}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@id": "HD50C70F339A44A2CAE1CCC5BE0F65D25", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "the development of\n\t\t\t\tnew therapeutics, including antimicrobial drugs, biologics, and\n\t\t\t devices against\n\t\t\t\tresistant pathogens, and in particular diseases for which few or no\n\t\t\t\ttherapeutics are in development;"}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "@id": "H8430DE64D2BD4B82A5EE0FEB6EBE43C5", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "the development\n\t\t\t\tand testing of medical diagnostics to identify patients with\n\t\t\t infectious disease\n\t\t\t\tand identify the exact cause of infectious diseases syndromes,\n\t\t\t particularly\n\t\t\t\twith respect to the detection of pathogens resistant to\n\t\t\t antimicrobial\n\t\t\t\tdrugs;"}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "@id": "H85762FBB7B924A8B9F0CAD754F2CFC85", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "the epidemiology,\n\t\t\t\tpathogenesis, mechanisms, and genetics of antimicrobial resistance;\n\t\t\t and"}, "enum": {"#tail": "\n              ", "#text": "(7)"}, "@id": "H123481648AFD4382BF090C402025B77B", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": "), in\n\t\t\t\tcollaboration with the ", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health Antimicrobial\n\t\t\t Advisory Board"}, {"#tail": " and the ", "@entity-type": "federal-body", "#text": "Department of Defense", "@entity-id": "9700"}, {"#tail": ".", "@entity-parent-id": "8900", "@entity-type": "federal-body", "#text": "Joint Genome\n\t\t\t Institute of\n\t\t\t\tthe Department of\n\t\t\t\tEnergy", "@value": "Joint Genome Institute"}], "#text": "the sequencing of\n\t\t\t\tthe genomes, or other DNA analysis, or other comparative analysis\n\t\t\t of priority\n\t\t\t\tpathogens (as determined by the "}, "enum": {"#tail": "\n              ", "#text": "(8)"}, "@id": "H61AE8E7176CB4523A47BF6327BE97920", "#text": "\n              "}], "#text": "\n            ", "@id": "HD7D40B0E51CB49CF9FE5C970B2A0629E"}, "#text": "\n          ", "@id": "H502786A87FD84AF489F3AD080FAC1FA4"}, "#text": "\n        ", "@id": "HD4EEFA3C50E7484789D7AE0B63B0A0A9"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subsection\n\t\t\t (c)", "@value": "Public Health Service Act/s:319E/ss:c"}, "#text": "in "}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "#text": "\n        ", "@id": "HE6D0F60523844F77A167B173B9F2F1D5", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "quote": [{"#tail": " after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ",", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the Antimicrobial Resistance\n\t\t\t Office"}, "#text": "acting through the "}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}], "#text": "by inserting\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H1411E0807F364FDD99E7BFBA15824832", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "quote": {"#tail": ";", "#text": "members of the task force described in subsection (a),"}, "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "HCBCA866710BD4369BD3E1C3DC03790C1", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by inserting ", "@entity-type": "act", "#text": "subsection\n\t\t\t (d)(1)", "@value": "Public Health Service Act/s:319E/ss:d/p:1"}, "#text": "in ", "quote": [{"#tail": " after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ",", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Antimicrobial Resistance\n\t\t\t Office"}, "#text": ", through the "}, {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}]}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "HF6FEF0E1E2374B55A96B7F23BC481873", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subsection\n\t\t\t (e)", "@value": "Public Health Service Act/s:319E/ss:e"}, "#text": "in "}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "#text": "\n        ", "@id": "HE4010A1C5A274B60AF89A449D43D184B", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "quote": {"#tail": ";", "header-in-text": {"#tail": "\n            ", "@style": "OLC", "#text": "Improving Uptake and Measurement of\n\t\t\t Antimicrobial Stewardship", "@level": "subsection"}, "#text": "\n              "}, "#text": "by amending the\n\t\t\t subsection heading to read as follows: "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H52819BE685964611A44D6B5E151F4491", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph\n\t\t\t (1)", "@value": "Public Health Service Act/s:319E/ss:e/p:1"}, "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "clause": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "quote": [{"#tail": " after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ",", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the Antimicrobial Resistance\n\t\t\t Office"}, "#text": ", acting through the "}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}], "#text": "by\n\t\t\t inserting "}, "enum": {"#tail": "\n            ", "#text": "(i)"}, "@id": "HC02F542DB3ED4622BF76E390450741FE", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "quote": [{"#tail": " and inserting ", "#text": "judicious use of antimicrobial drugs or control the spread of\n\t\t\t antimicrobial-resistant pathogens"}, {"#tail": ";", "#text": "the uptake and\n\t\t\t measurement of antimicrobial stewardship programs in the Nation\u2019s health\n\t\t\t care\n\t\t\t facilities"}], "#text": "by\n\t\t\t striking "}, "enum": {"#tail": "\n            ", "#text": "(ii)"}, "@id": "HE0F1C257D60B4CD19B754E649C7D7928", "#text": "\n            "}], "#text": "\n          ", "@id": "H0E8A04F5118247A7ADC56933D31A0AC3"}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t by striking ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Public Health Service Act/s:319E/ss:e/p:2"}, "#text": "in ", "quote": {"#tail": ";", "#text": "laboratory"}}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "HFEE2A44AA8FB49168F473B74A88AE938", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t by inserting ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Public Health Service Act/s:319E/ss:e/p:3"}, "#text": "in ", "quote": [{"#tail": " after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": ",", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Antimicrobial Resistance\n\t\t\t Office"}, "#text": ", acting through the "}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}]}, "enum": {"#tail": "\n          ", "#text": "(D)"}, "@id": "H3008138509504222812B3167B654B1DF", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n          ", "#text": "by adding at the\n\t\t\t end the following new paragraphs:"}, "enum": {"#tail": "\n          ", "#text": "(E)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": ";\n\t\t\t\t"}, "#tail": "\n        ", "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "term": {"#tail": " means coordinated interventions\n\t\t\t\tdesigned to improve and measure the appropriate use of\n\t\t\t antimicrobial agents,\n\t\t\t\tincluding promoting the use of antimicrobials only when clinically\n\t\t\t indicated,\n\t\t\t\tand, when antimicrobials are indicated, promoting the selection of\n\t\t\t the optimal\n\t\t\t\tantimicrobial drug regimen including dosing, duration of therapy,\n\t\t\t and route of\n\t\t\t\tadministration.", "#text": "antimicrobial stewardship"}, "#text": "For purposes of this subsection and\n\t\t\t\tAct, "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Definition of\n\t\t\t\tantimicrobial stewardship"}, "#text": "\n              ", "@id": "H3F093F8E7B114B4C80E84E2999EF2F60"}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Public Health Service Act/s:319E/ss:e/p:1"}, {"#tail": "\n\t\t\t\tshall give preference to eligible entities that will use grant\n\t\t\t funds to\n\t\t\t\testablish demonstration projects that lead to the development of\n\t\t\t quality\n\t\t\t\tmeasures for health care providers prescribing antimicrobial\n\t\t\t\tdrugs.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In making awards under "}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "header": {"#tail": "\n              ", "#text": "Preference in\n\t\t\t\tmaking awards"}, "#text": "\n              ", "@id": "H3A5B4BCD9C634367AE14A2FC60340A03"}], "#text": "\n            ", "@id": "H3F0F88C0950B4A4180E473BE6C2808E4"}, "#text": "\n          ", "@id": "HA2BF8A5A441D4651925FD8B9F6048695"}]}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "subsections (f)", "@value": "Public Health Service Act/s:319E/ss:f"}, {"#tail": " as ", "@entity-type": "act", "#text": "(g)", "@value": "Public Health Service Act/s:319E/ss:g"}, {"#tail": " and ", "@entity-type": "act", "#text": "subsections (i)", "@value": "Public Health Service Act/s:319E/ss:i", "@proposed": "true"}, {"#tail": ", respectively; and", "@entity-type": "act", "#text": "(j)", "@value": "Public Health Service Act/s:319E/ss:j", "@proposed": "true"}], "#text": "by redesignating\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "H57FA97A937294FF198141454678DB0CC", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following new subsections:", "@entity-type": "act", "#text": "subsection (e)", "@value": "Public Health Service Act/s:319E/ss:e"}, "#text": "by inserting after\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall take such\n\t\t\t additional\n\t\t\t\tactions as follows:", "@entity-type": "federal-body", "#text": "Director of\n\t\t\t\tthe Centers for Disease Control and Prevention", "@entity-id": "7523"}], "#text": "The "}, "enum": {"#tail": "\n            ", "#text": "(f)"}, "header": {"#tail": "\n            ", "#text": "Appropriate\n\t\t\t\tantimicrobial use"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall work with standard setting organizations (such as\n\t\t\t the National\n\t\t\t\tQuality Forum, the Joint Commission, and the National Committee for\n\t\t\t Quality\n\t\t\t\tAssurance) to determine if any such measure is suitable for\n\t\t\t national quality\n\t\t\t\treporting efforts.", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "7523"}, "#text": "To pilot and test\n\t\t\t\thealth care quality measures to help providers, facilities, and\n\t\t\t health systems\n\t\t\t\tmeasure and benchmark appropriate antimicrobial use. As\n\t\t\t appropriate, the\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "#text": "\n              ", "@id": "H7A82B8E916DC4809912629C9085A1938", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "To develop methods\n\t\t\t\tto help providers, facilities, and health systems measure and\n\t\t\t improve\n\t\t\t\tappropriate antimicrobial use, including methods and tools to\n\t\t\t assess the change\n\t\t\t\tin antimicrobial use, the impact on antibiotic resistance and\n\t\t\t adverse effects\n\t\t\t\t(such as Clostridium difficile infections), and the economic impact\n\t\t\t and cost\n\t\t\t\tsavings of antimicrobial stewardship programs."}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "H104BEC67DA7946C086DCB8CBD94F7355", "@commented": "no"}], "#text": "\n            ", "@id": "H9B2081F9150344E5B65C2D5D47B98A9D", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(g)"}, "header": {"#tail": "\n            ", "#text": "Collection of\n\t\t\t\thuman antimicrobial consumption and resistance trend data"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall work with private vendors, health care\n\t\t\t organizations, pharmacy\n\t\t\t\tbenefit managers, and other entities to obtain reliable and\n\t\t\t comparable human\n\t\t\t\tantimicrobial drug consumption data (including volume antimicrobial\n\t\t\t\tdistribution data and antimicrobial use, including prescription\n\t\t\t data) by State\n\t\t\t\tor metropolitan area.", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease Control and\n\t\t\t\tPrevention", "@entity-id": "7523"}, "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Antimicrobial\n\t\t\t\tUse Data"}, "#text": "\n              ", "@id": "HA4EFB088F7EB4A32ACA657BE41213268"}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall intensify and expand their efforts to\n\t\t\t collect\n\t\t\t\tantimicrobial resistance data including through the establishment\n\t\t\t of an\n\t\t\t\tAntimicrobial Resistance Surveillance and Laboratory Network,\n\t\t\t established in\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease\n\t\t\t\tControl and Prevention", "@entity-id": "7523"}, {"#tail": ", and\n\t\t\t\tdevelopment of a fully automated antimicrobial resistance and use\n\t\t\t module within\n\t\t\t\tthe National Healthcare Safety Network. The ", "@entity-type": "act", "#text": "section 4 of the Strategies to Address Antimicrobial Resistance\n\t\t\t Act", "@value": "Strategies to Address Antimicrobial Resistance Act/s:4", "@proposed": "true"}, {"#tail": " shall seek to\n\t\t\t collect data\n\t\t\t\tfrom electronic medication administration reports (eMAR) and\n\t\t\t laboratory systems\n\t\t\t\tto produce regular reports on antimicrobial resistance patterns and\n\t\t\t\tantimicrobial use.", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "7523"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Antimicrobial\n\t\t\t\tResistance Trend Data"}, "#text": "\n              ", "@id": "HAC5CD45C62824DC68FB921D0FE03AF47"}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall work with the ", "@entity-parent-id": "7500", "@entity-type": "federal-body", "#text": "Office of the National Coordinator for Health\n\t\t\t\tInformation Technology", "@value": "Office of the National Coordinator for Health Information Technology"}, {"#tail": " to determine how best antimicrobial use,\n\t\t\t susceptibility,\n\t\t\t\tand resistance data can be incorporated into meaningful use\n\t\t\t reporting.", "@entity-type": "federal-body", "#text": "Director of the Centers\n\t\t\t for Disease\n\t\t\t\tControl and Prevention", "@entity-id": "7523"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Meaningful Use\n\t\t\t\tReporting"}, "#text": "\n              ", "@id": "H445CFBF201A2488183EA4751C0ECFD53"}, {"#tail": "\n          ", "@id": "H72FEF540ECB44E279BD1EC1960A63B38", "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Report"}, "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and every two years thereafter, the\n\t\t\t ", "@entity-type": "act", "#text": "Strategies to Address\n\t\t\t\tAntimicrobial Resistance Act", "@value": "Strategies to Address Antimicrobial Resistance Act", "@proposed": "true"}, {"#tail": " shall submit to the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Director of\n\t\t\t\tthe Centers for Disease Control and Prevention", "@entity-id": "7523"}, {"#tail": " and the\n\t\t\t ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tEnergy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " and make\n\t\t\t available on the\n\t\t\t\tagency\u2019s website a report summarizing key trends and major issues\n\t\t\t related to\n\t\t\t\tantimicrobial resistance and use in the United States. Each such\n\t\t\t report shall\n\t\t\t\tinclude the most relevant and up-to-date data available from the\n\t\t\t infectious\n\t\t\t\tdiseases and surveillance programs of the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tHealth, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": ". Each such report shall\u2014", "@entity-type": "federal-body", "#text": "Centers for Disease\n\t\t\t Control and\n\t\t\t\tPrevention", "@entity-id": "7523"}], "#text": "Not\n\t\t\t\tlater than 2 years after the date of the enactment of the\n\t\t\t "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "outline major\n\t\t\t\tissues and threats in antimicrobial resistance facing the United\n\t\t\t States;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HC0CA37FAE69944569FC240DC6F9CAB88", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "provide data on\n\t\t\t\tthe incidence, prevalence, morbidity, mortality, and general\n\t\t\t societal burden,\n\t\t\t\tincluding economic, of antimicrobial resistant pathogens;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H0671E025C0434AFBAE2BC2DC97AC7B35", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "provide updates on\n\t\t\t\tresistance patterns and antimicrobials use data and potential\n\t\t\t impacts on human\n\t\t\t\thealth and patient safety;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H80CA4C72B8394F05BE1B16CF22A90A08", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t targeted toward\n\t\t\t\tmeasuring and preventing the spread of drug resistant pathogens;", "@entity-type": "federal-body", "#text": "Centers for Disease Control and Prevention", "@entity-id": "7523"}, "#text": "articulate\n\t\t\t\tactivities of the "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H9C7EB40AF71D4B76A77BA171E4C67714", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "describe any\n\t\t\t\tinternational developments that may impact antimicrobial resistance\n\t\t\t in the\n\t\t\t\tUnited States; and"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "H1F80BB61EA1A4A6C865F16D3D06F19B8", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "identify the major\n\t\t\t\tgaps that the Nation faces in the areas of antimicrobial resistance\n\t\t\t\tsurveillance, prevention, use, and antimicrobial stewardship."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "H4AA9A596552E48519D233BBF3C08CB6B", "#text": "\n                "}]}], "#text": "\n            ", "@id": "HC8E2B7F1B89A46EF8D6AB3F7BADEB518"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"@proposed": "true", "#tail": " shall work with the Federal agencies represented\n\t\t\t on the\n\t\t\t\t", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Director of the Antimicrobial\n\t\t\t\tResistance Office"}, {"@proposed": "true", "#tail": " to identify relevant data and\n\t\t\t formats, and\n\t\t\t\tmechanisms for communicating such data to the ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Antimicrobial Resistance Task Force"}, {"@proposed": "true", "#tail": "\n\t\t\t\tand ", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Office", "@entity-parent-id": "7500", "#text": "Antimicrobial\n\t\t\t Resistance Office"}, {"@proposed": "true", "#tail": " and, in a manner consistent\n\t\t\t with\n\t\t\t\t", "@entity-type": "federal-body", "@value": "Antimicrobial Resistance Task Force", "@entity-parent-id": "7500", "#text": "Antimicrobial Resistance Task Force"}, {"#tail": ", with the\n\t\t\t\t", "@entity-type": "act", "#text": "section 9 of the Strategies to Address Antimicrobial Resistance\n\t\t\t Act", "@value": "Strategies to Address Antimicrobial Resistance Act/s:9", "@proposed": "true"}, {"@proposed": "true", "#tail": " and the public,\n\t\t\t including relevant\n\t\t\t\tdata obtained by the agencies through contracts with other\n\t\t\t organizations,\n\t\t\t\tincluding\u2014", "@entity-type": "federal-body", "@value": "Public Health Antimicrobial Advisory Board", "@entity-parent-id": "7500", "#text": "Public Health Antimicrobial Advisory Board"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(h)"}, "header": {"#tail": "\n            ", "#text": "Ensure access to\n\t\t\t\tantimicrobial resistance data and research"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "use and clinical\n\t\t\t\toutcomes data on patients receiving antimicrobial drugs for the\n\t\t\t treatment,\n\t\t\t\tprevention, or diagnosis of infection or infectious diseases;"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "HF9691CC13CF04D6DA69454B7F994DBB7", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "surveillance data\n\t\t\t\tregarding emerging antimicrobial drug resistance and existing\n\t\t\t resistance\n\t\t\t\tpatterns;"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "H063064BACDF743E8B22F93797B6A2F9C", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "susceptibility\n\t\t\t\tdata related to antimicrobial drug use;"}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "H538E0CB7D10743A282156E1685CB470E", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "data related to\n\t\t\t\tthe amount of antimicrobial products used in humans, animals,\n\t\t\t plants, and the\n\t\t\t\tenvironment;"}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@id": "H0279BCE6F4B040AE999B7F52100F9159", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "data from\n\t\t\t\tfederally funded research intended to support antimicrobial drug,\n\t\t\t vaccine, and\n\t\t\t\trelated diagnostics development;"}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "@id": "H8FA4BC5C6C05486D9FF29F39C6AA8B59", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "data demonstrating\n\t\t\t\tthe impact of research, surveillance, and prevention and control\n\t\t\t initiatives in\n\t\t\t\tunderstanding and controlling antimicrobial resistance; and"}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "@id": "H5339E1C60AFB4ECEAA31064CD6690074", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "data regarding\n\t\t\t\timplementation and evaluation of interventions to improve\n\t\t\t antimicrobial drug\n\t\t\t\tprescribing\n\t\t\t\tpractices."}, "enum": {"#tail": "\n              ", "#text": "(7)"}, "@id": "HAE7EA68DDBEF4235AEFD8FBD066371D0", "#text": "\n              "}], "#text": "\n            ", "@id": "HB3DB51D8F608411297FD4BF0D1E26C69"}], "#text": "\n          ", "@id": "H23C3FB41360148DCA370145E9A092674"}, "#text": "\n        ", "@id": "HCFB5AE1BBB284EAAA2FB5EE61001F99D"}], "#text": "\n      ", "@id": "HEFAF86356A8C47D09EE271481DE91DF9"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Antimicrobial\n\t\t\t resistance surveillance and laboratory network"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting\n\t\t\t through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": ",\n\t\t\t shall establish\n\t\t\t at\n\t\t\t least 10 Antimicrobial Resistance Surveillance and Laboratory Network\n\t\t\t sites,\n\t\t\t building upon the intramural and extramural programs and laboratories of\n\t\t\t the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease Control and Prevention", "@entity-id": "7523"}, {"#tail": ", to intensify, strengthen, and\n\t\t\t expand the national capacity to\u2014", "@entity-type": "federal-body", "#text": "Centers for Disease Control and Prevention", "@entity-id": "7523"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "monitor the\n\t\t\t emergence and changes in the patterns of antimicrobial resistant\n\t\t\t pathogens;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H14358735982B4E15B8630D58B02371DD", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "describe, confirm,\n\t\t\t and as necessary facilitate a response to local or regional outbreaks of\n\t\t\t resistant pathogens;"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H5498A3A9CC2F4F7BB7BF30827BED40B8", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "assess and\n\t\t\t describe antimicrobial resistance patterns to inform public health and\n\t\t\t improve\n\t\t\t prevention practices;"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H1D97350F854B46DE9366DE2E12962F6A", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "obtain isolates of\n\t\t\t pathogens, and in particular, pathogens that show new or atypical patterns\n\t\t\t of\n\t\t\t resistance adversely affecting public health;"}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H265D852C9FBB405F9811D8294A9A6274", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "study the\n\t\t\t epidemiology of infections from such pathogens;"}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "HAA6EFB3EEBAD47C09EDC261EF7C076BD", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "evaluate commonly\n\t\t\t used antimicrobial susceptibility testing methods to improve the accuracy\n\t\t\t of\n\t\t\t resistance testing and reporting; and"}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "@id": "HFE70454581934FBFB4C00C8DA992C7AE", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "as necessary,\n\t\t\t develop novel diagnostic tests capable of detecting new or emerging\n\t\t\t resistance\n\t\t\t in pathogens."}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "@id": "H87E2498D614B4E33A8760174AA0EA0BB", "#text": "\n          "}], "#text": "\n        ", "@id": "H7C9031D5F87D4BF9940AE3A12BD8F852"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be\n\t\t\t geographically distributed across the United States.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Strategies to Address Antimicrobial Resistance Act/s:4/ss:a", "@proposed": "true"}, "#text": "The sites established under "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Geographic\n\t\t\t distribution"}, "#text": "\n        ", "@id": "H0C1D35ED0F274A1D9DCB0EA73D5C51A4"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may be based in academic centers, health departments, and\n\t\t\t existing surveillance and laboratory sites.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Strategies to Address Antimicrobial Resistance Act/s:4/ss:a", "@proposed": "true"}, "#text": "The sites established under\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Nonduplication\n\t\t\t of current national capacity"}, "#text": "\n        ", "@id": "HA95BBF5D18364A509610FBDFE0CB4F3B"}], "#text": "\n      ", "@id": "HC7D00DF9F421463E83E8E71DB46CBBCA"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "Clinical trials\n\t\t\t network on antibacterial resistance"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall establish a\n\t\t\t Clinical Trials Network on Antibacterial Resistance to enhance,\n\t\t\t strengthen, and\n\t\t\t expand research on clinical science, antibacterial and diagnostic\n\t\t\t development,\n\t\t\t and optimal usage strategies, and shall, at a minimum\u2014", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Director of the\n\t\t\t National Institute of Allergy and Infectious Diseases", "@value": "National Institute of Allergy and Infectious Diseases"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t General"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "facilitate\n\t\t\t research to better understand resistance mechanisms and how to prevent,\n\t\t\t control, and treat resistant organisms;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HCBEC3F74ED1E4501846B8FF375B99A0E", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "advance clinical\n\t\t\t trial efforts to develop antimicrobial therapies, vaccines and\n\t\t\t diagnostics, and\n\t\t\t evaluate and optimize their usage;"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HC36DAF99B1C048E19458F0F623659C04", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "conduct clinical\n\t\t\t research to develop natural histories of resistant infectious diseases;"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H30FFA122FF414A15AA9C45678B0BDB8A", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "examine patient\n\t\t\t outcomes with currently available antimicrobial therapy and validate and\n\t\t\t improve upon biomarkers and other surrogate end\u00adpoints; and"}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H025DDFC33FD840DBB26E7116642C313F", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "study shorter\n\t\t\t treatment duration and early cessation of antimicrobial therapy for\n\t\t\t treatment\n\t\t\t efficacy and effect on development of resistance."}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "H40C65419752E45F585BE30C85C6A0480", "#text": "\n          "}], "#text": "\n        ", "@id": "H896C8C73DCBB44F6BD26F2584569C769"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall establish a Leadership Group for the Clinical\n\t\t\t Research Network on Antibacterial Resistance described in ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "Director of the National Institute of\n\t\t\t Allergy and\n\t\t\t Infectious Diseases", "@value": "National Institute of Allergy and Infectious Diseases"}, {"#tail": "\n\t\t\t to\n\t\t\t develop and implement a comprehensive clinical research agenda to address\n\t\t\t antibacterial resistance that takes into consideration the recommendations\n\t\t\t contained in the Strategic Research Plan on Antimicrobial Resistance\n\t\t\t developed\n\t\t\t in accordance with ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Strategies to Address Antimicrobial Resistance Act/s:5/ss:a", "@proposed": "true"}, {"#tail": ". The\n\t\t\t Leadership Group shall provide support for the following components\u2014", "@entity-type": "act", "#text": "section 319E of the Public Health Service Act", "@value": "Public Health Service Act/s:319E", "@proposed": "true"}], "#text": "The\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Leadership Group\n\t\t\t for a Clinical Research Network on Antibacterial Resistance"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "scientific\n\t\t\t leadership and operations;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HBBD58F00923040B5B8D8EC6D2F2BF5F9", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "network\n\t\t\t laboratories; and"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H784579C7FF174A379F29BD792F6F85A1", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "statistical and\n\t\t\t data management."}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "HD22BF395A7A14F88B605DD17EAD95685", "#text": "\n          "}], "#text": "\n        ", "@id": "H00740224290D4D82A694A0206C271928"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", ", "@entity-parent-id": "7529", "@entity-type": "federal-body", "#text": "National\n\t\t\t Institute of Allergy and Infectious Diseases", "@value": "National Institute of Allergy and Infectious Diseases"}, "{http://namespaces.cato.org/catoxml}property": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "this section", "@value": "Strategies to Address Antimicrobial Resistance Act/s:5", "@proposed": "true"}, "#text": "to carry out ", "@name": "purpose"}, "#tail": "\n        ", "@entity-type": "auth-auth-approp", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": " ", "#text": "$100,000,000 annually for\n\t\t\t each of\n\t\t\t fiscal years 2015 through 2021", "@amount": "100000000", "@year": "2015, 2016, 2017, 2018, 2019, 2020, 2021"}, "#text": "There\n\t\t\t are authorized to be appropriated from the existing budget of the "}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Appropriations"}, "#text": "\n        ", "@id": "HFEAA14DA74F747F8BCF3EE94F2306DDE"}], "#text": "\n      ", "@id": "HD9DAC9BDE98C4BA381AE702F06936B26"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall work with State health departments to support regional\n\t\t\t prevention collaboratives designed to interrupt and prevent the\n\t\t\t transmission of\n\t\t\t significant antibiotic resistant pathogens being transmitted across health\n\t\t\t care\n\t\t\t settings in a geographic region. Such regional prevention collaboratives\n\t\t\t shall\n\t\t\t work to\u2014", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease Control\n\t\t\t and\n\t\t\t Prevention", "@entity-id": "7523"}], "#text": "The\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n      ", "#text": "Regional\n\t\t\t prevention collaboratives"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "identify\n\t\t\t significant drug resistant pathogens being transmitted across health care\n\t\t\t settings locally;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "HC410DA184C384FF6B0084AF4FA3D5AE6", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "implement\n\t\t\t evidence-based interventions to interrupt and prevent the transmission of\n\t\t\t such\n\t\t\t pathogens; and"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "HC8ABFC292A9E4A67910792F8BB9DD4F4", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "evaluate the\n\t\t\t impact of such measures on hospital readmissions, transitions of care,\n\t\t\t rates of\n\t\t\t health care associated infections, or any other relevant measures that\n\t\t\t characterize the health or economic impact of the collaboratives."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "HC0AB75367D5F4C4CB908FE11F6FD801D", "#text": "\n        "}], "#text": "\n      ", "@id": "H7FF4236440E94A85A235205F5A849D8C"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with tools,\n\t\t\t strategies, and evidence-based interventions, the ", "@entity-type": "act", "#text": "section 6", "@value": "Strategies to Address Antimicrobial Resistance Act/s:6", "@proposed": "true"}, {"#tail": " may intensify and expand academic public\n\t\t\t health\n\t\t\t partnerships through the work of the Prevention Epicenters Program of the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Director of the Centers\n\t\t\t for\n\t\t\t Disease Control and Prevention", "@entity-id": "7523"}, {"#tail": ". The ", "@entity-type": "federal-body", "#text": "Centers for Disease Control and Prevention", "@entity-id": "7523"}, {"#tail": " and the epicenters participating in such program shall work\n\t\t\t with the\n\t\t\t regional prevention collaboratives to\u2014", "@entity-type": "federal-body", "#text": "Centers for Disease\n\t\t\t Control\n\t\t\t and\n\t\t\t Prevention", "@entity-id": "7523"}], "#text": "To provide the\n\t\t\t regional prevention collaboratives established under ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "7."}, "header": {"#tail": "\n      ", "#text": "Prevention\n\t\t\t Epicenters"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "evaluate new and\n\t\t\t existing interventions to prevent or limit the emergence of antimicrobial\n\t\t\t resistance throughout the geographic region of the collaboratives;"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "#text": "\n        ", "@id": "HE8671FA9603D4D8D924A65DEB0DF6781", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "facilitate public\n\t\t\t health research on the prevention and control of resistant organisms;\n\t\t\t and"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "#text": "\n        ", "@id": "H3D7B5C7A74004C4B897229CAAB8ED477", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "assess the\n\t\t\t feasibility, cost-effectiveness, and appropriateness of surveillance and\n\t\t\t prevention programs in differing health care and institutional settings."}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "#text": "\n        ", "@id": "H2059E68D9E7446E4A761198668EE5396", "@commented": "no"}], "#text": "\n      ", "@id": "HE34012EB0CF740BEA4FAB1F856B291B9", "@commented": "no"}, {"#tail": "\n    ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is amended by inserting ", "@entity-type": "act", "#text": "section 3(6)", "@value": "Strategies to Address Antimicrobial Resistance Act/s:3/p:6", "@proposed": "true"}, "#tail": "\n    ", "quote": [{"#tail": " after ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n        ", "@entity-type": "auth-auth-approp", "#text": "\n          and ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": "\n          ", "#text": "for each of\n\t\t\t the fiscal years 2015 through 2019", "@amount": "indefinite", "@year": "2015, 2016, 2017, 2018, 2019"}}}, {"#tail": ".", "#text": "2006"}], "{http://namespaces.cato.org/catoxml}entity": {"#tail": ",\n\t\t\t as\n\t\t\t redesignated by ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subsection\n\t\t\t (j) of section 319E of the Public Health Service Act", "@value": "Public Health Service Act/s:319E/ss:j", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "\n          42 U.S.C. 247d\u20135", "@value": "usc/42/247d\u20135", "@proposed": "true"}, "@parsable-cite": "usc/42/247d-5", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline", "#text": "\n        "}, "enum": {"#tail": "\n      ", "#text": "8."}, "header": {"#tail": "\n      ", "#text": "Continuation of\n\t\t\t current programs"}, "#text": "\n      ", "@id": "HACC72A262F8B4BDBBD8F6740D2E1B0B5"}, {"#tail": "\n  ", "text": {"#tail": "\n    ", "#text": "Except as otherwise required by law, this\n\t\t\t Act (and the amendments made by this Act) shall not permit public\n\t\t\t disclosure of\n\t\t\t trade secrets, confidential commercial information, or material\n\t\t\t inconsistent\n\t\t\t with national security that is obtained by any person under this Act (or\n\t\t\t amendments made by this Act).", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "9."}, "header": {"#tail": "\n      ", "#text": "Protection of\n\t\t\t confidential and national security information"}, "#text": "\n      ", "@id": "H5C15B5E98C934559BB3735E940AFE487"}], "#text": "\n    ", "@id": "H54F647D5B719483890D5A46DEA932A4B"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-04-10"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2236 IS: Strategies to Address Antimicrobial Resistance Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}